The 4 key principles of a smart regulatory strategy for medical devices

Michael Robards recently moderated an insightful panel discussion at BIOMEDevice Silicon Valley on what it’s been like getting in-vitro diagnostic medical devices (IVD) to market over the last few years.

Planet Innovation is taking another step in providing a safe working environment for on-site staff by introducing voluntary COVID-19 rapid antigen testing at its Australian facility.

With the COVID-19 pandemic shining a light on the benefits of telehealth, there has never been a better time to be in remote patient monitoring (RPM). But if you’re going to be successful, you need to win over your two main users: patients and clinicians.

Over the past nine months, I’ve run multiple innovation workshops for clients entirely online. Here are some tips to ensure your virtual workshop is as engaging and productive as an in-person workshop.

Planet Innovation has been recognized as a leading example of resilience, innovation and excellence at the 41st Governor of Victoria Export Awards (GOVEAs).

Planet Innovation is using SteraMist® to disinfect its office and manufacturing premises to protect onsite manufacturing staff during the COVID-19 pandemic.

TOMI Environmental Solutions, a global company specializing in decontamination and disinfection, has selected Planet Innovation to manufacture its SteraMist® range of products used worldwide for infectious disease control, including to help fight the spread of COVID-19.

The first NOTUS Vivere emergency invasive ventilator has been produced at the Planet Innovation manufacturing facility.

NASA’s Jet Propulsion Laboratory has selected Planet Innovation as the only Australian manufacturer of a new ventilator tailored for COVID-19 patients.

Planet Innovation co-CEO and co-founder Stuart Elliott described the COVID-19 pandemic as a “wake-up call” for how medical products are sourced, in an interview with ABC Radio.

We are seeking GPs and other healthcare professionals in Victoria, Australia to pilot a new TGA-approved point-of-care test to help differentiate patients with viral from bacterial acute respiratory tract infections.